| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7070793 |
Antigen protein and nucleic acid coding for said protein |
Jul. 4, 2006 |
| 7071303 |
Androgen regulated prostate specific nucleic acids |
Jul. 4, 2006 |
| 7071322 |
HIV envelope polynucleotides and immunogenic composition |
Jul. 4, 2006 |
| 7067133 |
Methods and compositions for diseases associated with amyloidosis |
Jun. 27, 2006 |
| 7067135 |
Methods and compositions for the treatment and prevention of Staphylococcus aureus infections |
Jun. 27, 2006 |
| 7067136 |
Method of screening anti-mycobacterial molecules |
Jun. 27, 2006 |
| 7067138 |
Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
Jun. 27, 2006 |
| 7067247 |
Hepatitis B virus surface protein |
Jun. 27, 2006 |
| 7063841 |
Mammalian cell surface antigens; related reagents |
Jun. 20, 2006 |
| 7063846 |
Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
Jun. 20, 2006 |
| 7063847 |
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
Jun. 20, 2006 |
| 7063853 |
DNA immunization against Chlamydia infection |
Jun. 20, 2006 |
| 7063854 |
Composition and methods for WTI specific immunotherapy |
Jun. 20, 2006 |
| 7060277 |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins |
Jun. 13, 2006 |
| 7060279 |
Compositions and methods for dendritic cell-based immunotherapy |
Jun. 13, 2006 |
| 7060281 |
Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
Jun. 13, 2006 |
| 7060284 |
Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
Jun. 13, 2006 |
| 7060800 |
Antibodies binding the TNF related protein, TNF-X |
Jun. 13, 2006 |
| 7056512 |
Method for down-regulating GDF-8 activity |
Jun. 6, 2006 |
| 7056513 |
Telomerase |
Jun. 6, 2006 |
| 7056514 |
Partial peptide mimetics and methods |
Jun. 6, 2006 |
| 7056515 |
Antigens for immunocontraception |
Jun. 6, 2006 |
| 7056516 |
I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
Jun. 6, 2006 |
| 7056517 |
Glucosyltransferase immunogens |
Jun. 6, 2006 |
| 7052696 |
Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
May. 30, 2006 |
| 7052698 |
Surface proteins of Leptospira |
May. 30, 2006 |
| 7052699 |
Immunogenic composition |
May. 30, 2006 |
| 7052703 |
T-cell receptor.gamma. alternate reading frame protein, (TARP) and uses thereof |
May. 30, 2006 |
| 7053041 |
Methods and compositions useful for inhibition of .alpha..sub.v.beta..sub.5mediated angiogenesis |
May. 30, 2006 |
| 7053177 |
Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
May. 30, 2006 |
| 7048928 |
Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
May. 23, 2006 |
| 7048931 |
Compositions and methods for the therapy and diagnosis of prostate cancer |
May. 23, 2006 |
| 7049094 |
Methods for identifying modulators of N-type ion channel inactivation |
May. 23, 2006 |
| 7045133 |
VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
May. 16, 2006 |
| 7045134 |
Borellia burgdorferi epitope peptides |
May. 16, 2006 |
| 7045302 |
Expressed ligand-vascular intercellular signaling molecule |
May. 16, 2006 |
| 7045552 |
Pharmaceutical composition for improved administration of HIV gp41-derived peptides, and its use in therapy |
May. 16, 2006 |
| 7045596 |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
May. 16, 2006 |
| 7045597 |
Mast cell surface antigen, DNA thereof, and antibody against the antigen |
May. 16, 2006 |
| 7041297 |
Tumor antigen peptides originating in cyclophilin B |
May. 9, 2006 |
| 7041646 |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
May. 9, 2006 |
| 7037501 |
Myostatin immnoconjugate |
May. 2, 2006 |
| 7037502 |
Peptide with the amino acid sequence of KVLDGQDP having anti-inflammatory properties |
May. 2, 2006 |
| 7037510 |
Hybrids of M. tuberculosis antigens |
May. 2, 2006 |
| 7037676 |
Drosophila tumor necrosis factor class molecule polynucleotides and variants thereof |
May. 2, 2006 |
| 7033767 |
Genes regulating programmed cell death |
Apr. 25, 2006 |
| 7034137 |
Isolated mammalian membrane protein genes; related reagents |
Apr. 25, 2006 |
| 7033592 |
Surface proteins of leptospira |
Apr. 25, 2006 |
| 7033593 |
Immunogen comprising an HIV envelope protein, a ligand and H2 peptide |
Apr. 25, 2006 |
| 7029682 |
Inactivated vaccine against feline calicivirosis |
Apr. 18, 2006 |
|
|
|
